Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Net Income (2016 - 2025)

Solesence's Net Income history spans 16 years, with the latest figure at $163000.0 for Q4 2025.

  • For Q4 2025, Net Income rose 149.24% year-over-year to $163000.0; the TTM value through Dec 2025 reached $1.8 million, down 59.89%, while the annual FY2025 figure was $1.8 million, 57.73% down from the prior year.
  • Net Income reached $163000.0 in Q4 2025 per SLSN's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $3.0 million in Q3 2024 to a low of -$2.1 million in Q4 2023.
  • Average Net Income over 5 years is $79300.0, with a median of $56000.0 recorded in 2022.
  • Peak YoY movement for Net Income: surged 884.43% in 2021, then plummeted 1969.35% in 2023.
  • A 5-year view of Net Income shows it stood at -$357000.0 in 2021, then tumbled by 460.78% to -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then skyrocketed by 84.4% to -$331000.0 in 2024, then surged by 149.24% to $163000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Net Income are $163000.0 (Q4 2025), -$1.1 million (Q3 2025), and $2.7 million (Q2 2025).